Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Vera Bradley, Inc. (VRA)

Leather & Leather Products

https://www.verabradley.com

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the Most. Most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its product, and the company distributes the product through its distribution center in Indiana.

12420 STONEBRIDGE ROAD
ROANOKE, IN

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/21/2010

Market Cap

186,068,018

Shares Outstanding

30,830,000

Weighted SO

30,827,003

Total Employees

N/A

Upcoming Earnings

09/04/2024

Similar Tickers

RCKY --.--%

SHOO --.--%

WWW --.--%

CAL --.--%

WEYS --.--%

DBI --.--%

Beta

1.9100

Last Div

0.0000

Range

5.45-8.35

Chg

0.0600

Avg Vol

408714

Mkt Cap

186068018

Exch

NASDAQ

Country

US

Phone

877 708 8372

DCF Diff

0.8223

DCF

5.4277

Div Yield

0.0000

P/S

0.4071

EV Multiple

5.2216

P/FV

0.7867

Div Yield %

0.0000

P/E

44.0092

PEG

0.4004

Payout

0.0000

Current Ratio

3.4290

Quick Ratio

1.4421

Cash Ratio

0.8761

DSO

17.3576

DIO

215.6117

Op Cycle

232.9693

DPO

37.4349

CCC

195.5344

Gross Margin

0.5363

Op Margin

0.0194

Pretax Margin

0.0151

Net Margin

0.0096

Eff Tax Rate

0.3650

ROA

0.0119

ROE

0.0172

ROCE

0.0291

NI/EBT

0.6350

EBT/EBIT

0.7795

EBIT/Rev

0.0194

Debt Ratio

0.2113

D/E

0.3168

LT Debt/Cap

0.1954

Total Debt/Cap

0.2406

Int Coverage

9.0715

CF/Debt

0.5417

Equity Multi

1.4992

Rec Turnover

21.0282

Pay Turnover

9.7503

Inv Turnover

1.6929

FA Turnover

3.8872

Asset Turnover

1.2396

OCF/Share

1.3764

FCF/Share

1.2519

Cash/Share

1.8002

OCF/Sales

0.0923

FCF/OCF

0.9096

CF Coverage

0.5417

ST Coverage

2.3222

CapEx Coverage

11.0613

Div&CapEx Cov

11.0613

P/BV

0.7867

P/B

0.7867

P/S

0.4071

P/E

44.0092

P/FCF

4.8475

P/OCF

4.5846

P/CF

4.5846

PEG

0.4004

P/S

0.4071

EV Multiple

5.2216

P/FV

0.7867

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 21, 01:27 Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration GlobeNewswire Inc. Dec 06, 22:00 Zevra Therapeutics Announces Organizational Changes GlobeNewswire Inc. Nov 21, 21:51 Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C GlobeNewswire Inc. Aug 02, 21:50 FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C GlobeNewswire Inc. Jan 23, 07:30 Zevra Therapeutics Appoints Experienced Biopharma Executive Alvin Shih, MD, MBA, to the Board of Directors GlobeNewswire Inc. Jan 08, 07:30 Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C GlobeNewswire Inc. Jan 04, 08:55 Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officer Seeking Alpha Jan 04, 00:30 A Whole Lot Of Nothing At The Surface Seeking Alpha Jan 04, 00:30 A Whole Lot Of Nothing At The Surface Benzinga Dec 28, 08:35 Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday PennyStocks Dec 27, 16:57 Penny Stocks To Buy Before 2024? 3 For Your Watch List Now PennyStocks Dec 27, 16:57 Penny Stocks To Buy Before 2024? 3 For Your Watch List Now GlobeNewswire Inc. Dec 27, 07:30 Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration Seeking Alpha Dec 24, 01:02 Overbought Breadth Not Going Away Seeking Alpha Dec 24, 01:02 Overbought Breadth Not Going Away Seeking Alpha Dec 24, 01:02 Overbought Breadth Not Going Away Seeking Alpha Dec 24, 01:02 Overbought Breadth Not Going Away Seeking Alpha Dec 05, 00:10 The Fourth Quarter Started Slow, But It May Finish Strong GlobeNewswire Inc. Nov 20, 07:30 Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company Seeking Alpha Nov 10, 00:18 U.S. Could Soon See 2% Inflation

Revenue Product Segmentation